EISAI-E2020-A001-311

Study Sponsor: Eisai

Study Title

A Randomized, Double-Blind, Placebo-Controlled Evaluation of the Effects of Donepezil Hydrochloride (E2020) in the Management of Patients with Alzheimer's Disease in a Nursing Home Facility.

Medicine or Vaccine (generic name)

donepezil

Sponsor Identification Number

E2020-A001-311

Trial Registry Identification Number(#'s)

not available

Medical Condition

Alzheimer's Disease

Phase

Phase 3

Link to study details on the Eisai Clinical Study Register

not available

Link to study details on ClinicalTrials.gov (if available)

not available

Link to study details on EudraCT (if available)

not available

Datasets and Documents Available for this Study

Additional information about the data and documents available for this study

No restrictions.

Date Added to this Site

August 2019